tiprankstipranks
Advertisement
Advertisement

Taki Chemical Raises 2028 Medium-Term Plan Targets on Strong Performance

Story Highlights
  • Taki Chemical lifted its 2028 net sales, profit, and ROE targets after outperforming initial forecasts.
  • Stronger fertilizer and water treatment demand and capacity expansion underpin a strategy balancing growth and capital efficiency.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Taki Chemical Raises 2028 Medium-Term Plan Targets on Strong Performance

Claim 55% Off TipRanks

Taki Chemical Co., Ltd. ( (JP:4025) ) just unveiled an announcement.

Taki Chemical has revised the final-year targets of its Medium-Term Management Plan 2028, lifting net sales guidance from ¥42 billion to ¥44 billion and operating profit from ¥3 billion to ¥3.5 billion, while raising its return on equity goal from at least 6% to at least 7%. The upgrade follows stronger-than-expected results in the first two years, supported by higher fertilizer and water treatment chemical volumes, successful price hikes reflecting raw material cost increases, and broad-based segment growth, and the company aims to balance aggressive growth investments with disciplined capital efficiency and agile shareholder returns to enhance long-term corporate value.

The most recent analyst rating on (JP:4025) stock is a Hold with a Yen4266.00 price target. To see the full list of analyst forecasts on Taki Chemical Co., Ltd. stock, see the JP:4025 Stock Forecast page.

More about Taki Chemical Co., Ltd.

Taki Chemical Co., Ltd. is a Japan-based chemical manufacturer listed on the Prime Market of the Tokyo Stock Exchange. The company’s product portfolio includes fertilizers and water treatment chemicals, with a strategic focus on expanding production capacity in water treatment to drive growth across its business segments.

Average Trading Volume: 32,575

Technical Sentiment Signal: Buy

Current Market Cap: Yen34.74B

Find detailed analytics on 4025 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1